Framework for a national teleretinal imaging program to screen for diabetic retinopathy in Veterans Health Administration patients
Framework for a national teleretinal imaging program to screen for diabetic retinopathy in Veterans Health Administration patients
复制标题
DOI：
10.1682/jrrd.2005.08.0146
复制
发表时间：
2006-09-01
影响因子：
--
通讯作者：
Darkins, Adam W.
中科院分区：
文献类型：
--
作者：
Conlin, Paul R.;Fisch, Barry M.;Darkins, Adam W.
具有远程图像解释的数字视网膜成像（远程视网膜成像）是用于筛查糖尿病视网膜病变（DR）患者的新兴医疗保健技术。退伍军人健康管理局（VHA）于2001年召集了一个专家小组，以确定和解决与部署远程视网膜成像系统相关的必要临床、质量和培训、信息技术和医疗基础设施问题。该小组根据现有文献提出了协商一致的建议，并确定了值得进一步澄清或研究的不确定领域。随后的VHA远程视网膜成像经验和积累的科学证据支持远程视网膜成像在全国范围内的区域化部署，以筛查DR。目标是在2006年开始的该计划的第一年筛查约75，000名患者。该计划将增加患者接受DR筛查的机会，提供结果数据，并为系统评估该技术在糖尿病眼病护理和常规眼部护理实践中的作用提供独特的平台。
Digital retinal imaging with remote image interpretation (teleretinal imaging) is an emerging healthcare technology for screening patients for diabetic retinopathy (DR). The Veterans Health Administration (VHA) convened an expert panel in 2001 to determine and resolve the requisite clinical, quality and training, information technology, and healthcare infrastructure issues associated with deploying a teleretinal imaging system. The panel formulated consensus recommendations based on available literature and identified areas of uncertainty that merited further clarification or research. Subsequent VHA experience with teleretinal imaging and accumulated scientific evidence support nationwide regionalized deployment of teleretinal imaging to screen for DR. The goal is to screen approximately 75,000 patients in the first year of the program, which commenced in 2006. This program will increase patients' access to screening for DR, provide outcomes data, and offer a unique platform for systematically evaluating the role of this technology in the care of diabetic eye disease and routine eye-care practice.